BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 20699497)

  • 1. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Indirect immunofluorescence (IIF) alone as a screening method for antinuclear antibody in connective diseases in India's sub-Himalayan region.
    Kalita D; Rekha US; Raj AK; Mahanta P; Gupta P; Deka S
    Indian J Pathol Microbiol; 2022; 65(4):873-878. PubMed ID: 36308197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
    Sener AG; Afsar I; Demirci M
    APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
    Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
    Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
    Duran A; Çetin Duran A; Taşkıran İ
    Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and identification of significant ANAs in previously determined ANA negative samples.
    Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
    Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
    Desplat-Jego S; Bardin N; Larida B; Sanmarco M
    Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
    Peene I; Meheus L; Veys EM; De Keyser F
    Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
    Tonuttia E; Bassetti D; Piazza A; Visentini D; Poletto M; Bassetto F; Caciagli P; Villalta D; Tozzoli R; Bizzaro N
    Autoimmunity; 2004 Mar; 37(2):171-6. PubMed ID: 15293886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of panel testing for detection of antinuclear antibody in a resource-limited setting: an appraisal.
    Minz RW; Kumar Y; Saikia B; Anand S; Varma S; Singh S
    Postgrad Med; 2016 Nov; 128(8):869-874. PubMed ID: 27494797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
    Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.